Price Chart

Profile

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
URL https://www.pharming.com
Investor Relations URL https://www.pharming.com/investors/upcoming-events
HQ State/Province N/A
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release Mar. 14, 2025 (est.)
Last Earnings Release Oct. 24, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
URL https://www.pharming.com
Investor Relations URL https://www.pharming.com/investors/upcoming-events
HQ State/Province N/A
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release Mar. 14, 2025 (est.)
Last Earnings Release Oct. 24, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A